Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease

Add time:08/09/2019    Source:sciencedirect.com

BackgroundAlthough iodine 123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP) can assess abnormal utilization of fatty acid in the diseased myocardium, the prognostic value of BMIPP imaging at rest in patients with known or suspected coronary artery disease (CAD) remains unclear.

We also recommend Trading Suppliers and Manufacturers of 15-[4-(~123~I)iodophenyl]-3-Methylpentadecanoic acid (cas 123748-56-1). Pls Click Website Link as below: cas 123748-56-1 suppliers

Prev:Syndiotactic peptides for targeted delivery
Next:Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy)